Type 2 Diabetes Mellitus Completed Phase 3 Trials for Pioglitazone (DB01132)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus´╝îType 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01095666A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneTreatment
NCT00220961Actos Now for Prevention of Diabetes (ACT NOW)Prevention
NCT00683878Add-on to Thiazolidinedione (TZD) FailuresTreatment
NCT00680745Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsTreatment
NCT01225081A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic PatientsTreatment
NCT01894568A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin TreatmentTreatment
NCT02787551Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodTreatment
NCT00789750Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusTreatment
NCT00106808Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesTreatment
NCT00328627Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.Treatment
NCT00372060MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)Treatment
NCT00484198Randomized, Double-Blind Active Comparator-Controlled Study of Rivoglitazone in Type 2 Diabetes MellitusTreatment
NCT00541450A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)Treatment
NCT00532935MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)Treatment
NCT00637273A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)Treatment
NCT00676338Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)Treatment
NCT00722371MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)Treatment
NCT00885352Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)Treatment
NCT01076075A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)Treatment
NCT01106131Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to MetforminTreatment
NCT01156597Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With DiabetesBasic Science
NCT00328393Effect of Pioglitazone on Ambulatory Blood PressureTreatment
NCT00744367A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.Treatment
NCT00763815GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneTreatment
NCT00909597A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 DiabetesTreatment
NCT00094757An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)Treatment
NCT00121667Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin AloneTreatment
NCT00598793Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyTreatment
NCT01106690The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)Treatment
NCT01064687A Study in Participants With Type 2 Diabetes MellitusTreatment
NCT0118301330 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 WeeksTreatment
NCT00138554Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesTreatment
NCT00000620Action to Control Cardiovascular Risk in Diabetes (ACCORD)Prevention
NCT00849056Safety and Efficacy of Albiglutide in Type 2 DiabetesTreatment
NCT00839527A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesTreatment
NCT00641043Efficacy vs Placebo as Initial Combination Therapy With PioglitazoneTreatment
NCT00295633A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneTreatment
NCT00736099Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMTreatment
NCT00097279Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesTreatment
NCT00086502Pioglitazone Add-on Study in Patients With Type 2 Diabetes MellitusTreatment
NCT00099853Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesTreatment
NCT00106704Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)Treatment
NCT01289119Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesTreatment
NCT00086515Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)Treatment